237 related articles for article (PubMed ID: 24743216)
1. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
[TBL] [Abstract][Full Text] [Related]
2. Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.
Evason KJ; Grenert JP; Ferrell LD; Kakar S
Hum Pathol; 2013 May; 44(5):750-8. PubMed ID: 23084586
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
4. Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.
Nguyen TB; Roncalli M; Di Tommaso L; Kakar S
Mod Pathol; 2016 Mar; 29(3):283-92. PubMed ID: 26769138
[TBL] [Abstract][Full Text] [Related]
5. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
9. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
[TBL] [Abstract][Full Text] [Related]
10. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
Choi WT; Kakar S
Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
[TBL] [Abstract][Full Text] [Related]
11. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
12. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
[TBL] [Abstract][Full Text] [Related]
13. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum.
Joseph NM; Umetsu SE; Shafizadeh N; Ferrell L; Kakar S
Mod Pathol; 2019 Nov; 32(11):1627-1636. PubMed ID: 31189995
[TBL] [Abstract][Full Text] [Related]
14. Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.
Shafizadeh N; Ferrell LD; Kakar S
Mod Pathol; 2008 Aug; 21(8):1011-8. PubMed ID: 18536657
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical pitfalls in the diagnosis of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Bioulac-Sage P; Sempoux C; Balabaud C
Clin Res Hepatol Gastroenterol; 2014 Jun; 38(3):245-9. PubMed ID: 24525010
[No Abstract] [Full Text] [Related]
16. Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.
Kakar S; Chen X; Ho C; Burgart LJ; Adeyi O; Jain D; Sahai V; Ferrell LD
Histopathology; 2009 Aug; 55(2):197-205. PubMed ID: 19694827
[TBL] [Abstract][Full Text] [Related]
17. Expression of liver fatty acid binding protein in hepatocellular carcinoma.
Cho SJ; Ferrell LD; Gill RM
Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447
[TBL] [Abstract][Full Text] [Related]
18. Stromal morphological changes and immunophenotypic features of precancerous lesions and hepatocellular carcinoma.
Chen D; Li Z; Zhu W; Cheng Q; Song Q; Qian L; Zhu JY
J Clin Pathol; 2019 Apr; 72(4):295-303. PubMed ID: 30610005
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.
Choi WT; Kakar S
Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367
[TBL] [Abstract][Full Text] [Related]
20. From large to small: the immunohistochemical panel in the diagnosis of early hepatocellular carcinoma.
Vasuri F; Malvi D; Bonora S; Fittipaldi S; Renzulli M; Tovoli F; Golfieri R; Bolondi L; D'Errico A
Histopathology; 2018 Feb; 72(3):414-422. PubMed ID: 28881044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]